Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a mouse model of Friedreich’s ataxia. Butyrate prevents visceral adipose tissue inflammation and metabolic alterations in a mouse model of Friedreich’s ataxia

Functional enrichment analysis of differentially expressed genes reveals alteration of visceral adipose tissue resembling type 2 diabetes signatures in a mouse model of Friedreich’s ataxia Overall design: To compare frataxin deficient (KIKO) mice vs. WT, visceral adipose tissue (vWAT)